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Macrophages are permissive hosts to intracellular pathogens, but upon activation become microbiocidal effectors of
innate and cell-mediated immunity. How the fate of internalized microorganisms is monitored by macrophages, and
how that information is integrated to stimulate specific immune responses is not understood. Activation of
macrophages with interferon (IFN)–c leads to rapid killing and degradation of Listeria monocytogenes in a phagosome,
thus preventing escape of bacteria to the cytosol. Here, we show that activated macrophages induce a specific gene
expression program to L. monocytogenes degraded in the phago-lysosome. In addition to activation of Toll-like
receptor (TLR) signaling pathways, degraded bacteria also activated a TLR-independent transcriptional response that
was similar to the response induced by cytosolic L. monocytogenes. More specifically, degraded bacteria induced a TLR-
independent IFN-b response that was previously shown to be specific to cytosolic bacteria and not to intact bacteria
localized to the phagosome. This response required the generation of bacterial ligands in the phago-lysosome and was
largely dependent on nucleotide-binding oligomerization domain 2 (NOD2), a cytosolic receptor known to respond to
bacterial peptidoglycan fragments. The NOD2-dependent response to degraded bacteria required the phagosomal
membrane potential and the activity of lysosomal proteases. The NOD2-dependent IFN-b production resulted from
synergism with other cytosolic microbial sensors. This study supports the hypothesis that in activated macrophages,
cytosolic innate immune receptors are activated by bacterial ligands generated in the phagosome and transported to
the cytosol.
Citation: Herskovits AA, Auerbuch V, Portnoy DA (2007) Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog 3(3):
e51. doi:10.1371/journal.ppat.0030051
Introduction
Macrophages are highly phagocytic cells that can act as
benign scavengers, sentinels of microbial infection, and hosts
to intracellular pathogens [1]. However, a key property of
macrophages is their capacity to be immunologically acti-
vated by cytokines such as interferon (IFN)–c. Subsequent to
phagocytosis of microorganisms, activation is manifested as
an enhanced microbiocidal, degradative, and secretory
capacity concomitant with maturation of phagosomes into
acidic hydrolytic compartments [2]. How macrophages
couple microbiocidal and degradative activity with the
development of an appropriate immune response is critical
to understanding the regulation of inﬂammation.
Recognition of microorganisms by the innate immune
system is mediated by invariable pattern recognition recep-
tors (PRRs) that bind conserved molecules present on
microorganisms, referred to as pathogen-associated molec-
ular patterns (PAMPs). Among PRRs are the Toll-like
receptors (TLRs), type I integral membrane proteins located
at the cytoplasmic membrane and internal membrane-bound
compartments, and nucleotide-binding oligomerization do-
main (NOD) proteins located in the cell cytosol [3,4].
Microbial structures exposed on the bacterial cell surface,
such as lipopolysacaccharide (LPS), peptidoglycan (PGN), and
ﬂagellin, are recognized by TLR4, 2, and 5, respectively, which
are localized to the host cell surface. In contrast, microbial
nucleic acids are recognized by TLR3, 7, and 9, which are
located within intracellular membrane-bound compartments
that can fuse with phagosomes during their maturation.
Treatments of cells with agents that block vacuolar acid-
iﬁcation abrogate responses mediated by TLR3, 7, and 9 [5,6].
Whereas TLRs detect microorganisms extracellularly or
within the luminal side of the phagosome, the NOD-like
receptor family may comprise a surveillance system that
recognizes intracellular pathogens, leading to both transcrip-
tional responses and activation of the inﬂammasome [7].
Among the cytosolic innate immune receptors, RIG-I and
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NOD2 recognize bacterial PGN degradation products [7–12].
Engagement of innate immune receptors with speciﬁc
microbial ligands results in signaling pathways that culminate
in host transcriptional responses associated with inﬂamma-
tion. Signaling pathways are characterized by their shared
adaptor molecules. For example, MyD88 is a major adaptor
that mediates immune responses downstream of all TLRs
except TLR3, leading primarily to activation of nuclear factor
(NF)–jB [13]. Interaction of MyD88 with TLR7 and 9 can also
lead to the induction of type I IFN response through
activation of interferon regulatory factor (IRF) 3/7. TLR3
and TLR4 can both induce type I IFN responses via another
adaptor molecule, called Trif (Lps2), again through the
activation of IRF3 [13,14]. The cytosolic receptors that
recognize RNA and DNA signal by interacting with the
mitochondrial membrane adaptor MAVS/VISA/IPS-1/Cardif
[15], leading to activation of IRF3 and production of IFN-b.
Less is known about the signaling pathways downstream of
the NOD proteins, although NOD1 and NOD2 interact with
the adaptor molecule Rip2 (RICK) to activate NF-jB [16].
Type I IFNs have been studied extensively with regard to
their role as anti-viral cytokines, but their role in response to
bacterial infection has been less studied, although bacterial
LPS derived from Gram-negative bacteria is clearly an
inducer of type I IFN [17]. Recently, it was shown that a
Gram-positive pathogen, Listeria monocytogenes, induces type I
IFN, but only upon entry into the host cell cytosol [18–21].
Mutants lacking the secreted pore-forming protein listerio-
lysin O (LLO) fail to escape from a phagosome and fail to
induce IFN-b. Recognition of LLO-minus L. monocytogenes in
the phagosome is largely MyD88-dependent, while recogni-
tion of cytosolic bacteria is MyD88-independent and IRF3-
dependent [18–21]. The nature of the bacterial ligand(s) and
the host PRRs responsible for the activation of IRF3 in
response to cytosolic L. monocytogenes are not known, although
bacterial DNA can recapitulate this response [22]. The
production of type I IFN in response to L. monocytogenes is
enigmatic, as mice lacking the IFNa/b receptor are more
resistant to listeriosis [23–25].
A role of type I IFNs in the induction of acquired immunity
has become increasingly recognized, and it has been
suggested that a key feature of effective adjuvants is the
capacity to induce type I IFN [26]. However, NOD2, the target
of one of the most powerful adjuvants (muramyl dipeptide
[MDP] derived from bacterial PGN), has not been associated
with the expression of type I IFNs. In this report, we show that
activated macrophages express IFN-b after phagocytosis and
degradation of L. monocytogenes, and that NOD2 is necessary
for full expression. IFN-b induction by LLO-minus bacteria
was dependent on the activity of the macrophage vacuolar
ATPase, not for acidiﬁcation of the phagosome but for the
generation of the phagosomal membrane potential which, we
hypothesize, has a role in the active transport of bacterial
ligands into the cytosol.
Results
Bacteria Degraded in the Phagosome Trigger Distinct
Transcriptional Responses in IFN-c–Activated
Macrophages
It was previously demonstrated that macrophages respond
differently to bacteria located in their cytosol (e.g., wild-type
[w.t.] L. monocytogenes), compared to bacteria trapped in a
phagosome (e.g., LLO-minus L. monocytogenes) [18,19]. Cyto-
solic bacteria trigger an MyD88-independent production of
IFN-b, whereas phagosomal bacteria do not [20,21]. However,
these observations were based on the response of macro-
phages that were not activated and consequently weakly
bacteriocidal. In vivo, during L. monocytogenes infection,
cytokines such as IFN-c act on macrophages to render them
highly bacteriocidal and therefore less permissive for L.
monocytogenes replication [27]. We reasoned that the bacter-
iocidal activity of macrophages, such as killing and degrada-
tion of bacteria, would directly affect the innate immune
response to L. monocytogenes infection. In order to test this
hypothesis, we studied the response of IFN-c–activated
macrophages to infection with w.t. L. monocytogenes and an
LLO-minus mutant. The bacteriocidal activity of macro-
phages was best demonstrated when peritoneal macrophages
were infected with L. monocytogenes (Figure 1A). Growth curves
of L. monocytogenes in activated peritoneal macrophages
showed dramatic killing of w.t. bacteria. The number of
bacteria recovered from the activated peritoneal macro-
phages decreased during 6 h of infection, while in non-
activated peritoneal macrophages, bacteria were subjected to
initial killing, but survivors continued to grow (Figure 1A).
Infection of peritoneal macrophages with the LLO-minus
mutant resulted in killing of bacteria even without IFN-c
treatment (Figure 1A). Unlike in peritoneal macrophages, the
bacteriocidal activity of bone marrow–derived (BMD) macro-
phages was less profound and was completely dependent on
IFN-c treatment. Growth curves of w.t. L. monocytogenes in IFN-
c–activated BMD macrophages showed that IFN-c treatment
initially restricted the growth of w.t. L. monocytogenes, although
bacteria were still able to escape to the cytosol and replicate
(Figure 1B). The bactericidal activity of BMD macrophages
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Author Summary
Innate immune recognition of microorganisms has a direct impact
on the type and the magnitude of the immune response elicited.
While recognition of microorganisms relies on receptors that sense
pathogen-associated molecular patterns, (PAMPs), it was reasonable
to suspect that immune cells could discriminate between live and
dead bacteria. Listeria monocytogenes is an intracellular pathogenic
bacterium used extensively as a model system for studying basic
aspects of innate and acquired immunity. L. monocytogenes is
internalized by macrophages, escapes from a vacuole, multiplies
within the cytosol, and spreads from cell to cell without lysing the
cells. We used wild-type and bacterial mutants of L. monocytogenes
to demonstrate that macrophages not only respond differently to
bacteria that are growing in the cytosol and to non-growing
bacteria that are trapped in a vacuole, but that they also can
discriminate between intact or degraded bacteria in the vacuole. We
showed that macrophages induce specific immune response when
bacteria are killed and degraded. This response was directly
correlated to the ability of macrophages to degrade bacteria and
involved receptors that were located in the host cell cytosol. These
observations led us to suggest that bacterial degradation products
may serve as messengers that inform immune cells that bacteria
were killed and degraded. This information might affect directly the
immune response, for example, by down-regulating inflammatory
responses that can be deleterious. We call these bacterial
degradation products PAMP-PM (PAMP–post-mortem).Figure 1. L. monocytogenes Is Killed and Degraded in IFN-c–Activated Macrophages, Leading to a Specific Activation Program
(A) Intracellular growth curve of w.t. L. monocytogenes (L.m.) and LLO-minus mutant (LLO-) in IFN-c–activated ( ) versus non-activated (&) resident
peritoneal macrophages.
(B) Intracellular growth curve of w.t. L. monocytogenes and LLO-minus mutant in IFN-c–activated ( ) versus non-activated (&) BMD macrophages.
(C) Immunofluorescence microscopy of BMD macrophages infected with GFP-expressing, w.t. L. monocytogenes and LLO-minus mutant at 4 h.p.i.
Macrophage actin was stained in red with rhodamine-phalloidin. Lower panel, staining of acidic vesicles with LysoTracker RED in LLO-minus and w.t. L.
monocytogenes infections (w.t. infection is also stained with cuomarin-phalloidin for actin labeling in blue). Immunofluorescence data are representative
of 90% of the infected macrophages in two independent experiments.
(D) Macrophages transcriptional response to w.t. L. monocytogenes and LLO-minus mutant infection with and without activation of IFN-c. Only the most
changed genes upon bacterial infection of non-activated macrophages are presented (253 genes vary 5.6-fold and up). Genes were clustered using
Pearson hierarchical clustering. All columns were normalized to uninfected macrophages (un) without IFN-c treatment. Rows colorimetrically represent
expression ratios of individual genes as describe in material and methods.
(E) Presentation of selected genes (cytosolic-induced, phagosomal-induced, and both) and their expression profile in activated and non-activated
macrophages infected with w.t. L. monocytogenes and LLO-minus bacteria.
doi:10.1371/journal.ppat.0030051.g001
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NOD2 Senses Ligands Generated in the Phagosomewas best observed when the cells were infected with the LLO-
minus mutant. Like in peritoneal macrophages, a one-log
decrease in the number of LLO-minus bacteria was recovered
after 6 h of infection (Figure 1B). Since BMD macrophages
killed phagosomal-trapped bacteria only upon IFN-c activa-
tion, and w.t. L. monocytogenes were still able to escape to the
cytosol in activated BMD macrophages, we chose to use these
cells to study further the effect of the bacteriocidal activity on
the innate immune response to L. monocytogenes. To examine
whether L. monocytogenes were subjected to lysis in phago-
somes, activated BMD macrophages were infected with w.t. L.
monocytogenes or an LLO-minus mutant expressing cytosolic–
green ﬂuorescent protein (GFP). Immunoﬂuorescence micro-
scopy revealed that at 6 hours post-infection (h.p.i.), most w.t.
bacteria were cytosolic, as many of them were engaged with
actin tails, showed by co-localization of the GFP bacteria with
the actin marker rhodamine-phalloidin. Only a few w.t.
bacteria were labeled just with GFP, suggesting that they were
trapped in the phagosome (Figure 1C). Infection with a GFP-
expressing LLO-minus mutant revealed that non-activated
macrophages contained one to two intact GFP-expressing
bacteria per cell, whereas in activated macrophages the GFP
was released from the bacteria and distributed in multiple
vacuoles around the cell (Figure 1C). While we don’t know the
precise composition of these vacuoles, co-localization of some
of the GFP-labeled vacuoles with the pH-sensitive dye
LysoTracker RED suggested that they might have originated
from the primary phagosome during its maturation to a
phago-lysosome (Figure 1C). As a control, w.t. L. monocytogenes
did not localize with LysoTracker RED labeling (Figure 1C).
These results indicated that macrophage activation led to an
enhanced degradative activity and trafﬁcking of host-gen-
erated bacterial ligands, which potentially can be sensed by
the innate immune system.
In order to study the innate immune response of activated
macrophages to L. monocytogenes infection, we used Mouse
Exonic Evidence Based Oligonucleotide (MEEBO) micro-
arrays [28]. Analysis of the gene expression proﬁles of IFN-c–
activated and non-activated BMD macrophages infected with
w.t. L. monocytogenes and an LLO-minus mutant were
performed. Consistent with previous studies, the response
of non-activated macrophages to infection with w.t. L.
monocytogenes and the LLO-minus mutant clustered into three
groups of genes: i) genes that are largely induced by w.t.
cytosolic bacteria (i.e. cytosolic-induced genes), ii) genes that
are largely induced by phagosomal LLO-minus bacteria (i.e.,
phagosomal-induced genes), and iii) genes that are induced
by both cytosolic and phagosomal bacteria (Figure 1D; 253
genes vary . 5.6-fold). Analysis of these genes in IFN-c–
activated macrophages infected with w.t. or LLO-minus
bacteria reveled that many of the genes that were cytosolic
or phagosomal-speciﬁc in non-activated macrophages were
induced by both bacteria in IFN-c–activated macrophages
(Figure 1D). As expected, w.t. L. monocytogenes triggered
expression of genes from the ‘‘phagosomal-speciﬁc genes’’
category in the activated macrophages. Under these con-
ditions, some w.t. bacteria failed to escape to the cytosol and
remained trapped in the phagosome; consequently, they
induced phagosomal-speciﬁc genes as well (Figure 1B and
1C). Pro-inﬂammatory cytokines such as interleukin (IL)–12
and IL-1a, which are normally induced by LLO-minus
bacteria, were highly induced by w.t. cytosolic bacteria in
activated macrophages compared to non-activated macro-
phages (Figure 1E). Conversely, LLO-minus bacteria induced
many ‘‘cytosolic-speciﬁc genes’’ upon activation of macro-
phages, including the most highly induced gene in the
macrophages’ response to w.t. L. monocytogenes, IFN-b (Figure
1E). Like IFN-b, other cytosolic-speciﬁc genes that are
normally induced by w.t. bacteria, such as IL-15, chemokine
CXC ligand 11, chemokine C-C receptor like 2, and type I
IFN–related genes, were also induced by LLO-minus bacteria
in activated macrophages (Figure 1E). Interestingly, IFN-b was
among the 20 most induced genes in activated macrophages
infected with LLO-minus mutant (out of 12,344 genes total),
together with Nos2, ubiquitin D, and C-C receptor like 2
(Table S1). Since the IFN-b response to w.t. L. monocytogenes is
well established, we were interested in whether the IFN-b
response to LLO-minus bacteria shares common signaling
pathways. Further validation of IFN-b induction by the LLO-
minus mutant in activated macrophages was performed using
quantative real-time PCR (Q-RT-PCR) analysis. A time course
analysis of ifnb expression during w.t. L. monocytogenes
infection demonstrated that ifnb induction increased 10-fold
in activated macrophages compared to non-activated macro-
phages (Figure 2A). Upon infection with an LLO-minus
mutant, activated macrophages induced ifnb to the same level
as in response to w.t. L. monocytogenes (Figure 2A). This was also
the case when activated peritoneal macrophages were
infected with the LLO-minus mutant (Figure S1). These
results demonstrated that bacteria trapped in the degradative
phago-lysosomes of activated macrophages trigger the in-
duction of IFN-b, a response seen in non-activated macro-
phages only by bacteria able to access the cytosol. An obvious
consequence of bacterial degradation is the release of
bacterial ligands, such as nucleic acids, that are not normally
exposed by either live bacteria or killed, but non-degraded,
bacteria. It is possible that these bacterial degradation
products triggered the induction of IFN-b by activated
macrophages infected with LLO-minus mutant.
Since several TLRs are known to induce IFN-b through the
adaptor molecules MyD88 and Trif, we used macrophages
isolated from mice lacking each one of these adaptors to
examine their role in the IFN-b response to degraded
bacteria. Whereas ifnb induction was slightly reduced in
Trif-deﬁcient macrophages, it was completely abolished in
MyD88-deﬁcient macrophages (Figure 2B). However, exami-
nation of IFN-c–activated myd88
 /  macrophages infected
with LLO-minus GFP-expressing mutants revealed a defect in
bacterial degradation. While in C57BL/6 macrophages,
bacteria were lysed as shown by GFP distribution, in
MyD88-deﬁcient macrophages the LLO-minus mutant re-
mained intact even 6 h.p.i (Figure 2C). Growth curves of the
LLO-minus mutant in MyD88-deﬁcient activated macro-
phages revealed a slight decrease in bacterial colony-forming
units (CFUs) when compared to non-activated macrophages,
suggesting that MyD88-deﬁcient macrophages have a defect
in killing of the LLO-minus mutant (Figure S1). This result,
although striking, made it impossible to decipher the precise
role played by MyD88 in the ifnb induction by LLO-minus
mutants (see discussion below).
Since IFN-b induction occurs downstream of TLR3, 7, and
9, which are involved in nucleic acid recognition, we
examined the possibility that bacterial nucleic acids, possibly
released upon bacterial degradation, trigger IFN-b produc-
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mice lacking individual TLR3, 7, and 9 were infected with the
LLO-minus mutant to test their involvement in bacterial
nucleic acid recognition. Somewhat surprisingly, none of
these TLRs had any detectable affect on the induction of ifnb
by LLO-minus L. monocytogenes (Figure 2D).
NOD2 Detects Bacterial Ligands Generated in the
Phagosomes
Since none of the TLRs seemed to be playing a role in the
detection of LLO-minus L. monocytogenes, we considered other
host receptors that recognize bacterial ligands. NOD1 and
NOD2 are cytosolic proteins that are activated by muropep-
tides derived from bacterial PGN [29]. Surprisingly, NOD2
was involved in production of IFN-b in response to the LLO-
minus mutant, as macrophages from NOD2-minus mice
expressed and secreted 50% of IFN-b (Figure 3A). The
induction of IFN-b by w.t L. monocytogenes or an LLO-minus
mutant was independent of NOD1 (Figure 3A). Although nod2
gene expression was induced by both w.t L. monocytogenes and
LLO-minus bacteria (Figure 1D), it affected only the IFN-b
response to phagosomal bacteria (LLO-minus) and not to
cytosolic w.t. bacteria (Figure 3A). Unlike NOD2, the tran-
scriptional regulator IRF3 was required for IFN-b production
by both vacuolar and cytosolic bacteria, suggesting that both
pathways share common adaptors downstream of the signal-
ing pathways leading to type I IFN response (Figure 3B).
This is the ﬁrst report to our knowledge that links NOD2
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Figure 2. IFN-b Expression by LLO-Minus Mutant Is independent of TLR3, 7, and 9
(A) Time course analysis of ifnb induction by w.t. L. monocytogenes (L.m.) and LLO-minus mutant (LLO-) in non-activated and IFN-c–activated BMD
macrophages. Analysis of IFN-b mRNA by Q-RT-PCR at 2, 4, and 6 h.p.i. un, uninfected macrophages.
(B) Analysis of ifnb induction in response to the LLO-minus mutant after infection of MyD88- and Trif-deficient activated BMD macrophages by Q-RT-
PCR at 6 h.p.i.
(C) Immunofluorescence microscopy of MyD88 and C57BL/6 activated BMD macrophages infected with the GFP-expressing LLO-minus mutant at 6
h.p.i.
(D) Analysis of ifnb induction in response to the LLO-minus mutant after infection of TLR3-, 7-, and 9–deficient activated BMD macrophages by Q-RT-
PCR. Data correspond to the mean 6 standard error of the mean (s.e.m.) (triplicate determinations) and are representative of three or more
independent experiments. Immunofluorescence data are representative of 90% of the infected macrophages in two independent experiments.
doi:10.1371/journal.ppat.0030051.g002
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NOD2 Senses Ligands Generated in the Phagosomeactivation with type I IFN responses. MDP, the well-studied
ligand of NOD2, does not induce IFN-b when delivered to the
cytosol (Figure 3C). However, as NOD2 synergizes with other
receptors for cytokine production [30–34], we tested the
possibility that the IFN-b production in response to degraded
bacteria was a result of synergism between NOD2 and other
innate immune receptors. MDP was delivered with poly(I:C) (a
dsRNA analog that is sensed by phagosomal and cytosolic
receptors) to the activated macrophage cytosol. Whereas
poly(I:C) alone led to production of IFN-b, when combined
with MDP, the amount of IFN-b secreted by macrophages was
40% higher than with poly(I:C) alone (Figure 3C). This
increase in IFN-b production was dependent on NOD2,
demonstrating that NOD2 can synergize with other receptors
leading to an enhanced type I IFN response.
Degradation of Bacteria and Phagosomal Membrane
Potential Are Required for the Induction of IFN-b
Since the IFN-b response to phagosomal-degraded bacteria
required the cytosolic receptor NOD2, we hypothesized that
bacterial ligands were generated and transported from the
phagosome and detected in the cytosol. In order to test
whether degradation of bacteria is a prerequisite for IFN-b
induction by LLO-minus mutants, we treated activated
macrophages with baﬁlomycin A, a speciﬁc inhibitor of the
vacuolar ATPase proton pump (V-ATPase). Baﬁlomycin A
inhibits phagosome acidiﬁcation and blocks maturation of
phagosomes to phago-lysosomes. Baﬁlomycin A–treated
macrophages indeed failed to degrade internalized LLO-
minus mutants (Figure 4A), and did not induce ifnb (Figure
4B), whereas this treatment had no effect on induction of ifnb
by cytosolic L. monocytogenes (Figure 4B). To distinguish
between the requirement of degradation of bacteria or of
acidiﬁcation of the phagosome for IFN-b signaling, we used
alternative endosomal acidiﬁcation inhibitors, monensin or
nigericin, which act differently than baﬁlomycin A. Monensin
and nigericin are electro-neutral monovalent cation ex-
changers that are widely used to exchange K
þ/H
þ ions across
biological membranes [35]. In the presence of active V-
ATPase, treatment with monensin or nigericin will induce
intra-phagosomal accumulation of K
þ ions as a result of
exchange with luminal H
þ (Figure 4C). This will lead to
neutralization of vacuolar pH without changing the vacuolar
membrane potential [35]. Neither addition of nigericin nor
monensin blocked the induction of ifnb; in fact, both resulted
in the enhanced induction of ifnb (Figure 4C), while
neutralizing the phagosomal pH as determined by Lyso-
Tracker RED staining (unpublished data). Combining baﬁlo-
mycin A with monensin (or nigericin) or baﬁlomycin A alone
Figure 3. Role of NOD2 in the IFN-b Response to L. monocytogenes in Activated Macrophages
(A) Analysis of ifnb induction by Q-RT-PCR and IFN-b secretion (ELISA) by L. monocytogenes (L.m.) and the LLO-minus mutant (LLO-) in activated, NOD2-,
and NOD1-deficient BMD macrophages. The level of induction in NOD2
 /  was compared to macrophages from w.t. NOD2 mice littermates. un,
uninfected macrophages.
(B) Analysis of ifnb induction (Q-RT-PCR) by L. monocytogenes and the LLO-minus mutant in activated, IRF-3–deficient BMD macrophages in comparison
to C57BL/6 macrophages. un, uninfected macrophages.
(C) ELISA analysis of IFN-b amounts secreted by NOD2-deficient BMD macrophages in response to 100 lg/ml MDP and 100 lg/ml poly(I:C) delivered
with lipofectamine. Data correspond to the mean 6 s.e.m (triplicate determinations) and are representative of three or more independent experiments.
doi:10.1371/journal.ppat.0030051.g003
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induction originated from acidic (phago-lysosome) compart-
ments (Figure 4C). Immunoﬂuorescence microscopy revealed
that monensin treatment did not block phagosome matura-
tion and bacterial degradation in activated macrophages
except when combined with baﬁlomycin A (Figure 4D). These
results demonstrated that while acidiﬁcation of the phag-
osome was not required for IFN-b signaling, phagosome
maturation and bacterial degradation were necessary for this
response to LLO-minus mutants.
Figure 4. Effects of Phagosome Acidification and Phagosomal Membrane Potential on IFN-b Expression
(A) Immunofluorescence microscopy of C57BL/6 BMD macrophages infected with GFP-expressing LLO-minus mutant (LLO-) with and without
bafilomycin A treatment (6 h.p.i.).
(B) Q-RT-PCR analysis of ifnb induction in response to L. monocytogenes (L.m.) and the LLO-minus mutant with and without bafilomycin A treatment
(BafA). Bafilomycin A was added 30 min post-infection.
(C) Effect of the ionophors monensin, nigericin, and valinomycin on IFN-b response to the LLO-minus mutant, analyzed by Q-RT-PCR. Schematic
presentation of the phagosome, ionophor mode of action, and H
þ and K
þ ion transfer across the phagosomal membrane. (a.) V-ATPase, which
generates an electrochemical potential (w), inside positive and acidic. (b.) Monensin or nigericin, which establish a chemical K
þ gradient by
electroneutral H
þ/K
þ exchange (c.) Valinomycin, which dissipates the electrical potential by electrogenic efflux of K
þ.
(D) Immunofluorescence microscopy of C57BL/6 BMD macrophages infected with GFP-expressing LLO-minus mutant under ionophor treatments. All
ionophors were added 30 min post-infection.
(E) Effect of monensin (Mon) and chymostatin (Chym) on the IFN-b and IL-12p40 response to LLO-minus mutant in NOD2-deficient cells and NOD2 w.t.
cells, analyzed by Q-RT-PCR. Data correspond to the mean 6 s.e.m. (triplicate determinations) and are representative of three or more independent
experiments. Immunofluorescence data are representative for 99% of the infected macrophages in two independent experiments.
doi:10.1371/journal.ppat.0030051.g004
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NOD2 Senses Ligands Generated in the PhagosomeSince the V-ATPase contributes to the electrochemical
potential across the phagosomal membrane [36], baﬁlomycin
A treatment also results in dissipation of phagosomal
membrane potential, which is not the case with monensin
and nigericin [37]. We asked whether the phagosomal
membrane potential was important for IFN-b signaling. In
order to address this question, we dissipated the phagosomal
membrane potential of monensin-treated cells by using the
K
þ-speciﬁc ionophor valinomycin. Valinomycin transports K
þ
ions in accordance with existing chemical gradients, which
together with monensin treatment results in leakage of
accumulated K
þ ions from the phagosome to the cytosol
and, consequently, depolarization of the phagosomal mem-
brane (Figure 4C). Treatment of valinomycin resulted in
lower levels of ifnb induction, although it did not affect
degradation of bacteria (Figure 4C and 4D). These results
suggest that the phagosomal membrane potential is required
for IFN-b signaling in response to the LLO-mutant.
Next, we tested the role of NOD2 in the enhanced
production of IFN-b by monensin treatment; interestingly,
the induction of IFN-b was reduced by 4-fold in NOD2-
deﬁcient macrophages (Figure 4E). Possibly, monensin treat-
ment impaired the signaling from TLRs that require acidic
pH [5], leading to a greater effect on IFN-b expression in the
NOD2-deﬁcient macrophages. Importantly, NOD2 depend-
ency was speciﬁc for a subset of cytokines like IFN-b, as other
cytokines like IL-12p40, which are induced by TLRs, were
unaffected by the NOD2 mutation (Figure 4E).
Recently, it was demonstrated that potassium ion ﬂux plays
a role in the activation of several proteases in the phagocytic
vacuole of neutrophils [38]. Since treatment with monensin
generates an inﬂux of potassium ions into the phagosome, we
were interested in whether lysosomal proteases play a role in
the enhancement of IFN-b signaling by monensin treatment.
In order to test this hypothesis, we treated cells with the
protease inhibitor, chymostatin, which inhibits lysosomal
serine and cysteine proteinases and several cathepsins.
Chymostatin treatment resulted in a 4-fold decrease in the
ifnb expression and had no additional effect in NOD2-
deﬁcient macrophages (Figure 4E). Moreover, chymostatin
treatment was also speciﬁc to ifnb induction and had no effect
on il-12p40 induction (Figure 4E). These results suggest that
bacterial lysis and further digestion by lysosomal proteases
are required for generation of a NOD2 ligand, leading to ifnb
induction.
L. monocytogenes PGN Is Degraded in the Phago-
Lysosome and Can Induce NOD2-Dependent Signaling
NOD2 is activated by MDP, but how MDP is generated and
transported to the cytosol is unknown. The phago-lysosome
contains enzymes that can potentially degrade PGN of
bacteria, such as lysozyme [39]. However, while L. monocyto-
genes PGN is resistant to lysozyme cleavage [40], we asked
whether it is still cleaved in the phago-lysosomes of activated
macrophages. In order to address this question, we labeled
the PGN of LLO-minus bacteria prior to infection with
ﬂuorescent vancomycin (FL-Van) that binds speciﬁcally to the
terminal D-alanyl-D-alanine moieties of PGN [41]. Vancomy-
cin labeling is localized to sites of nascent PGN synthesis,
which results in polar bacterial staining (Figure 5A). Whereas
in non-activated macrophages we could detect intact bac-
teria, in activated macrophages the FL-Van PGN labeling was
distributed in large vacuoles, most likely due to bacterial cell
wall (CW) breakdown (Figure 5A). The FL-Van PGN labeling
was localized to acidic vacuoles determined by LysoTracker
RED staining (not shown). While labeling of intracellular
bacteria with FL-Van was not as efﬁcient as the GFP labeling,
we were able to detect large vacuoles (larger then a bacterial
cell) in which the FL-Van labeling was equally distributed,
suggesting that the bacterial PGN was released in these
vacuoles.
Next, we examined whether L. monocytogenes PGN contains a
NOD2 ligand and whether it can induce cytokines production
in a NOD2-dependent manner. The CW fraction of L.
monocytogenes was puriﬁed and treated with RNAse A and
DNAse I to prevent nucleic acids contamination. While L.
monocytogenes intact CW induces tumor necrosis factor (TNF) a
and IL-6, that response was independent of NOD2 (Figure
5B). When the CW was degraded in vitro with the muramidase
mutanolysin that speciﬁcally cleaves the PGN glycan back-
bone (NAG-NAM), the degradation products (like MDP)
triggered TNFa and IL-6 induction, which was largely
dependent on NOD2 (Figure 5B). The delivery of CW
fragments and MDP to the macrophages cytosol was mediated
by lipofectamine, which resulted in a 5-fold increase in the
response to these ligands. Interestingly, only CW-derived
fragments and not intact CW or MDP itself induce ifnb.
However, this induction was only partially (30%) dependent
on NOD2 (Figure 5B). Since IFN-b expression was induced by
puriﬁed bacterial CW fragments, we addressed the role of
MyD88 and Trif in ifnb induction. We found that neither of
these adaptors was required for ifnb induction, raising the
possibility that cytosolic microbial sensors are involved in this
response (Figure 5C). These results demonstrated that L.
monocytogenes PGN contains a NOD2 ligand that becomes
accessible only after degradation with a muramidase, and that
it can induce a pro-inﬂammatory response when delivered to
the cytosol. However, the exact nature of the PGN fragments
generated in the phago-lysosome and the in vivo ligand
recognized by NOD2 are not yet known.
Discussion
We have investigated the relationship between two
fundamental processes of macrophages, degradation of
bacteria and induction of innate immune response. In vivo,
IFN-c has a major role in controlling L. monocytogenes
infection. By activating immune cells such as macrophages,
IFN-c enhances the bacteriocidal activity of macrophages and
renders them less permissive to L. monocytogenes replication. In
this study, we used the LLO-minus mutant to ask whether the
bacteriocidal activity of macrophages has a role in the innate
immune response to L. monocytogenes infection. Here, we show
that phagosomal-degraded bacteria induce a speciﬁc innate
immune response that is different than the response to
phagosomal intact bacteria. We found that phagosomal-
degraded bacteria induced type I IFN, a response that was
previously shown to be speciﬁc to intracellularly growing L.
monocytogenes. This research report shows that the cytosolic
receptor NOD2 enhances the induction of IFN-b by
phagosomal-trapped L. monocytogenes, but only when these
bacteria are killed and degraded in the phago-lysosomes of
IFN-c–activated macrophages. To our knowledge, this is the
ﬁrst study to demonstrate that bacterial breakdown products
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NOD2 Senses Ligands Generated in the Phagosomegenerated in the phago-lysosome are targets for intracellular
innate immune sensors. This study suggests that induction of
IFN-b in response to L. monocytogenes in vivo might result from
two distinct signaling pathways, one of them largely depend-
ent on NOD2 [20]. These results are consistent with a model
in which bacterial breakdown products generated in the
phagosome are transported to the cytosol, where they are
detected by cytosolic microbial innate immune receptors.
NOD2 is activated by small muropeptides derived from
bacterial PGN [29,42]. Although MDP (MurNAc-L-Ala-D-Gln)
was shown to be the minimal motif recognized by NOD2, the
natural ligand(s) sensed by NOD2 in vivo are not known.
Mammals and bacteria contain muramidases, like lysozyme,
or in the case of bacteria, lytic transglycosylases, that can
generate muropeptide analogs of MDP such as GlcNAc-
MurNAc-L-Ala-D-Gln [43]. However, only bacteria are known
to possess the endopeptidases with the speciﬁcity to generate
the NOD2 ligands. For example, L. monocytogenes secrets a
highly expressed endopeptidase, p60, that cleaves the bond
between D-Glu and meso-DAP, thus potentially generating
NOD2 ligands [44]. In the phago-lysosome, L. monocytogenes is
potentially subjected to degradation by both bacterial and
host enzymes. We found that protease inhibitors blocked the
NOD2-dependent response without affecting the TLR-
dependent response. Therefore, lysosomal proteases might
contribute to degradation of the bacterial CW, thereby
facilitating further digestion of the PGN. A role for proteases
was most evident upon H
þ/K
þ ionophors treatment. Interest-
ingly, a role for potassium inﬂux and protease activation in
neutrophils has been proposed by Reeve et al. [38]. These
investigators have suggested that potassium inﬂux into
phagocytic vacuoles results in the release of cationic
proteases from the anionic sulphated proteoglycan matrix,
thus resulting in microbial degradation. During treatment
with H
þ/K
þ ionophors that cause a phagosomal potassium
inﬂux, we found that protease inhibitors blocked the IFN-b
expression, but had no affect on expression of IL-12p40,
suggesting that proteolysis is necessary to generate the
Figure 5. L. monocytogenes PGN Is Degraded in the Phago-Lysosome and Induces NOD2-Dependent Responses
(A) Immunofluorescence microscopy of activated and non-activated BMD macrophages infected with FL-Van–labeled LLO-minus mutant. FL-Van
labeling localized to bacterial poles (arrowheads and magnified picture).
(B) Response of activated macrophages to L. monocytogenes CW preparation and CW degradation fragments (L.m.CW fragments) delivered with
lipofectamine. Level of TNFa, IL-6, and IFN-b induction determined by Q-RT-PCR.
(C) Induction of IFN-b response by L. monocytogenes CW fragments in Myd88/Trif double-knockout activated macrophages. Data correspond to the
mean 6 s.e.m. (triplicate determinations).
doi:10.1371/journal.ppat.0030051.g005
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NOD2 Senses Ligands Generated in the Phagosomeligands transported to the cytosol, but not those recognized
in the phagosome. Taken together, these results show that
phagosomal degradation of L. monocytogenes resulted in the
NOD2-dependent production of IFN-b, presumably due to
the production of the appropriate muramyl dipeptide(s)
generated during bacterial degradation.
NOD1 and NOD2 are cytosolic proteins that are activated
by small PGN fragments. Although the mechanism(s) that lead
to PGN entry into the cytosol are not known, it was suggested
that a speciﬁc transport system might be involved [45]. In the
case of cytosolic pathogens such as Shigella ﬂexneri or L.
monocytogenes, it is possible that NOD1 and NOD2 recognize
PGN fragments released during bacterial growth [46,47]. In
addition, NOD1 and NOD2 may be activated by PGN
fragments, introduced into host cells during infection by
pathogens that possess auxiliary secretion systems. Indeed,
activation of NOD1 occurred upon infection of epithelial
cells by Helicobacter pylori [48]. A third hypothesis, consistent
with our data, is that bacterial products leak or are actively
transported from the phagosome to the cytosol [1]. An
example for active transport of NOD2 ligands was demon-
strated in epithelial cells where the peptide transporter
hPepT1 was shown to transport MDP into the colonic
epithelial cells, leading to NF-jB activation [45]. Although
the mechanism of transport in macrophages is not known,
here we present pharmacological evidence that the phag-
osomal membrane potential is crucial for NOD2-dependent
IFN-b responses. While monensin and valinomycin treat-
ments did not affect degradation of bacteria, addition of
valinomycin to monensin-treated cells resulted in dissipation
of the phagosomal membrane potential and reduction in
IFN-b response. This observation leads to a hypothesis that
the phagosomal membrane potential could have a direct role
as a driving force for transport of ligands into the cytosol, or
might be involved indirectly by affecting the function of
membrane proteins involved in the transport process.
There are a number of well-characterized host signal–
transduction pathways stimulated by viral and/or bacterial
products that result in the production of type I IFN [17].
Intriguingly, DNA and RNA are recognized by both intra-
cellular TLRs and by caspase recruitment domain (CARD)–
containing cytosolic proteins, both leading to type I IFN
production. Therefore, we initially hypothesized that the
induction of IFN-b by degraded L. monocytogenes was likely
associated with one of these TLRs, as bacterial nucleic acids
are undoubtedly released into the phagosome upon bacter-
iolysis. However, none of the individual TLR knockouts had a
measurable affect on the production of IFN-b, although it is
still possible that there is an overlapping affect of individual
TLRs. Recently, two cytosolic dsRNA helicases with CARD-
domains, RIG-I and MDA5, have been identiﬁed and shown to
lead to IFN-b production in response to viral nucleic acids by
interacting with the mitochondrial membrane adaptor called
MAVS/VISA/IPS-1/Cardif [15]. Interestingly, microarray data
revealed that whereas MDA5 is induced only by w.t. L.
monocytogenes in non-activated macrophages, it is induced by
both w.t. and LLO-minus bacteria in activated macrophages
(Figure 1D). Since L. monocytogenes DNA and RNA prepara-
tions were able to induce IFN-b when delivered to the cytosol
(A. Herskovits, unpublished data; [22]), it is possible that
cytosolic nucleic-acids sensors such as MDA5 and RIG-I are
contributing to the expression of IFN-b in response to
degraded L. monocytogenes.
This report has demonstrated that NOD2 activation
enhances IFN-b production, and although we do not know
the exact nature of this signaling pathway, since NOD2
contains two CARD domains, we speculate that it may be
interacting with other CARD-containing adapters. Whereas
puriﬁed MDP, the synthetic activator of NOD2, did not lead
to IFN-b production, when combined with poly (I:C), it
enhanced the induction of IFN-b in a NOD2-dependent
manner. Our in vitro preparation of CW fragments recapitu-
lated the induction of IFN-b when delivered to the macro-
phage’s cytosol. However, this induction was only partially
dependent on NOD2. Since NOD2 is known to act synergisti-
cally with other innate immune receptors [30–34], we suggest
that the NOD2-dependent IFN-b response is a result of
synergism between PGN fragments generated in phagosomes
and other bacterial ligands exposed upon bacterial lysis.
Interestingly, it was recently shown that delivery of L.
monocytogenes DNA to the cytosol promotes IFN-b production
[22], raising the possibility that release of bacterial nucleic
acids in the cytosol might be involved in type I IFN response
to degraded bacteria.
This study highlights the downstream consequences that
result from the enhanced microbiocidal and degradative
capacity of IFN-c–activated macrophages. Whereas non-
activated macrophages show some bacteriocidal capacity,
only activated macrophages killed and degraded bacteria.
Bacterial degradation has a number of potential immuno-
logical consequences. A well-established consequence of
phagosomal degradation is the generation of bacterial
peptides ligands, which leads to the development of major
histocompatibility complex class II–dependent responses
[49]. In this study, we show that digestion of bacteria in a
phagosome results in induction of speciﬁc innate immune
responses that differ from a response to intact bacteria. We
demonstrated a direct correlation between bacterial degra-
dation and macrophage expression of IFN-b. Macrophages
that failed to degrade bacteria failed to express IFN-b.
Blocking degradation of bacteria by baﬁlomycin A treatment
resulted in loss of signaling. While the role of the V-ATPase in
phago-lysosome maturation is well characterized, we found
that the signaling adaptor MyD88 was also essential for
bacterial degradation. MyD88-deﬁcient macrophages failed
to degrade bacteria or express IFN-b when presented with
intact bacteria, but did express IFN-b when bacterial CW
fragments were delivered directly to the cytosol. Although the
role of MyD88 in phagosome maturation is controversial, it is
possible that MyD88 is involved in the initial signaling
pathways that promote macrophage activation and their
capacity to kill and degrade bacteria. Indeed, it was shown
that the induction of many genes by IFN-c is dependent on
MyD88 [50]. Recently, it was suggested that MyD88 is required
for proper assembly of the phagosomal NADPH oxidase, thus
affecting the killing of Gram-negative bacteria [51]. It is clear
that immune signaling pathways affect cellular processes in
specialized phagocytic cells, but how these processes, such as
pathogen digestion and generation of new ligands, are
involved in further shaping the immune response is less
understood. We speculate that macrophages can discriminate
between ligands that are presented by live bacteria or ligands
that are generated after degradation of bacteria (post-
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NOD2 Senses Ligands Generated in the Phagosomemortem). We refer to these ligands as pathogen-associated
molecular patterns post-mortem (PAMP-PM). The results of
this study suggest that a fully active phagosome provides
PAMP-PM for detection by the innate immune system.
However, this ‘‘information’’ is not restricted to receptors
that are located in the phagosome, but crosses the phag-
osomal membrane to activate intracellular immune receptors
as well. Lastly, we suggest that bacterial degradation in the
phagosome plays a major role in the development of innate
and acquired immune responses.
Materials and Methods
Bacterial strains. The L. monocytogenes strains used were a w.t. strain,
10403S and 10403S expressing GFP, or strains containing in-frame
deletions of the hly gene (LLO, DP-L2161) [52] and DP-L2161
expressing GFP [53]. Single colonies were inoculated into 2 ml of
BHI broth (brain-heart infusion) and incubated overnight at 30 8C
without shaking.
Mice. C57BL/6 mice were obtained from The Jackson Laboratory
(http://www.jax.org). CD-1 mice were obtained from Charles River
Laboratory (http://www.criver.com). All knockout mice used in this
study were on the C57BL/6 background or backcrossed with C57BL/6
mice for at least eight generations. Femurs or mice were obtained
from the following source: myd88
–/– from R. Medzhitov, Yale
University School of Medicine, New Haven, Connecticut; tlr3
 / ,
tlr7
 / , tlr9
 /  from K. A. Fitzgerald and D. Golenbock, University of
Massachusetts Medical School, Worcester, Massachusetts; trif
 /  (lps2/
lps2), myd88trif
 / , from B. Beutler, The Scripps Research Institute, La
Jolla. California; nod2
 /  [54] from V. Dixit, Genentech, South San
Francisco, California; nod1
 /  from Millennium, Cambridge, Massa-
chusetts; irf3
 /  from G. Cheng, Department of Microbiology,
Immunology and Molecular Genetics, University of California, Los
Angeles, California.
Cell culture, infections, and treatments. Primary cultures of
resident peritoneal macrophages were prepared from CD-1 mice as
previously described [27]. BMD macrophages were isolated from 6- to
8-wk-old female mice and cultured as described [55]. Activation of
macrophages was done by incubating macrophage monolayer with 1
ng/ml recombinant murine IFNc (Biosource, http://www.biosource.
com) for 36 h before infection and during infection. Approximately 8
310
6 w.t. L. monocytogenes or 1310
8 LLO-minus bacteria were used to
infect 2310
6 macrophages cells seeded on a 60-mm petri dish. These
numbers resulted in infection of one to two bacteria per cell in the
case of w.t. L. monocytogenes, and ;25–50 bacteria per cell in the case of
the LLO-minus mutant. Thirty minutes after addition of bacteria,
macrophage monolayers were washed three times with PBS, and fresh
medium was added. At 1 h.p.i., gentamicin was added to 50 lg/ml to
limit the growth of extracellular bacteria. Unless indicated otherwise,
infections were completed at 6 h.p.i, and further analyzed. Activation
of macrophages was conﬁrmed by visual inspection after infection
with GFP-expressing bacteria (Figure 1C). Where indicated, 0.5 lM
baﬁlomycin A (Sigma, http://www.sigmaaldrich.com), 1 lM monensin
(Sigma), 0.1 lM nigericin (Sigma), 1 lM valinomycin (Sigma), were
added at 30 min post-infection. The protease inhibitor chymostatin
(100 lM) (Sigma), was added at the time of infection. Growth curves
of L. monocytogenes in macrophages cells were performed as described
earlier [27].
Microarrays. MEEBO microarrays were printed at the Center for
Advanced Technology at University of California San Francisco [28].
Each microarray experiment was done in triplicate. Macrophages
were infected with w.t. and LLO-minus mutant for 5 h with and
without IFN-c treatment. Then, macrophages were washed with PBS,
and total RNA was extracted using RNAqueous kit (Ambion, http://
www.ambion.com). A half microgram of RNA was ampliﬁed using
Amino Allyl MessageAmp II aRNA Ampliﬁcation Kit (Ambion). A
total of 5 lg of ampliﬁed RNA from each sample was labeled
ﬂuorescently with Cy5 (Amersham, http://www.gelifesciences.com)
and mixed with a Cy3 (Amersham)–labeled reference pool. The
common reference pool contained equal amounts (5 lg of each) of
ampliﬁed RNA from all the samples analyzed in the experiment
(including uninfected, hly, and w.t. samples from activated and non-
activated macrophages). RNA was hybridized to the MEEBO micro-
arrays for 48 h. Microarrays were gridded using SpotReader software
(Niles Scientiﬁc, http://www.nilesscientiﬁc.com) and GenePix Pro 6
(Molecular Devices, http://www.moleculardevices.com), and analyzed
using Acuity 4 software (Molecular Devices). Highest quality spots
meeting extra-stringent criteria were identiﬁed. These highest quality
spots were used to calculate normalization factors such that the
median Cy5/Cy3 ratio was brought to 1. These factors were then
applied to the entire dataset after removing low quality spots. Finally,
all arrays were normalized to the uninfected non-activated macro-
phages array. Signiﬁcant analysis of microarrays (SAM) algorithm was
used with two-class unpaired designs to identify genes that were
differentially expressed in w.t. versus LLO-minus infection of non-
activated macrophages, and in LLO-minus mutant infections of
activated versus non-activated macrophages. Genes that showed a 5.6-
fold or greater difference were selected for further analysis. Pearson
hierarchical clustering was applied on selected genes.
L. monocytogenes CW preparation and delivery. One liter of L.
monocytogenes culture was grown at 37 8C to exponential phase and
used for CW preparation. Bacterial cells were lysed by three passages
through a French press at 12,000 PSI, and treated with DNAse I
(Invitrogen, http://www.invitrogen.com). After removal of cell debris,
supernatant was added drop by drop to 8% boiling SDS with stirring,
and was boiled for an additional 30 min [56]. The mixture was cooled
overnight at room temperature, and washed with hot water. CW was
washed in 0.1% Triton X-100, and then washed six times with water
and stored at 20 8C. Mutanolysin treatment was done overnight in 50
mM MES (pH 5.88), 1 mM MgCl2. Insoluble CW was pelleted and the
supernatant pH was adjusted. CW preparation and CW fragments
were treated with RNAse A (Fermentas, http://www.fermentas.com). L.
monocytogenes CW fragments, 100 lg/ml MDP (Calbiochem, http://www.
emdbiosciences.com/html/CBC/home.html) and 100 lg/ml poly(I:C)
(Invivogen), were delivered to macrophage cytosol with Lipofect-
amine 2000 (Invitrogen).
Q-RT-PCR. RNA was harvested from macrophages at 6 h.p.i. using
RNeasy Mini kit (Qiagen, http://www.qiagen.com). To synthesize
cDNA, 1 lg of total RNA, M-MLV reverse transcriptase, Random
Primers, and RNaseOUT ribonuclease inhibitor (Invitrogen) were
used. For regular PCR analysis, 1 lg of cDNA was used with speciﬁc
primers. SYBR Green based quantitative PCR ampliﬁcation was
performed in 96-well plates using SYBR Green PCR core reagents
(Applied Biosystems, http://www.appliedbiosystems.com), the Strata-
gene Mx3000P Real-Time PCR System (http://www.stratagene.com),
and a 60 8C annealing temperature. For each indicated gene, as well
as to the reference gene (actin), a standard curve was generated to
calculate the quantity of mRNA as function of the Ct value. The level
of expression of each gene was determined by normalizing its mRNA
quantity to the quantity of the actin mRNA at the same sample. The
following mouse primer sequences were designed using Applied
Biosystems Primer Express software: ifnb-F: 59-ctggagcagctgaatggaaag;
ifnb-R: 59-cttgaagtccgccctgtaggt; b-actin-F: 59-aggtgtgatggtgggaatgg; b-
actin-R: 59-gcctcgtcacccacatagga; tnfa-F: 59-gcaccaccatcaaggactcaa;
and tnfa-R: 59-tcgaggctccagtgaattcg; il-6-F: 59-ttccatccagttgccttcttg;
and il-6-R: 59-gaaggccgtggttgtcacc; il-12p40-F: 59- aaccatctcctggtttgcca;
and il-12p40-R: 59- cgggagtccagtccacctc.
Measurement of IFN-b. IFN-b was measured by a mouse IFN-b
enzyme-linked immunoassay (ELISA) kit (R&D Systems, http://www.
rndsystems.com).
Labeling of bacteria and immunoﬂuorescence. Bacterial PGN was
labeled as described by Daniel and Errington [41]. A mixture of 1:1
FL-Van (Molecular Probes, http://probes.invitrogen.com) and unla-
beled vancomycin (Sigma) was added to growing cultures to a ﬁnal
concentration of 1 lg/ml. The culture was then incubated for 30 min
at 37 8C to allow absorption of the antibiotic and then washed four
times in PBS. For immunoﬂuorescence microscopy, FL-Van–labeled
bacteria or GFP-expressing bacteria were used to infect macrophages
on 18-mm
2 glass cover slips. LysoTracker RED staining was
performed according to manufacturer instructions (Molecular
Probes). Then, 4 h.p.i., macrophages were washed once with PBS
and ﬁxed in 4% paraformaldehyde. Cover slips were incubated with
coumarin-phalloidin or tetramethylrhodamine B isothiocyanate-
phalloidin (Sigma, 1:1,000 dilution) for cytosolic F-actin staining
and mounted with Vectashield mounting medium with DAPI (Vector
Laboratories, http://www.vectorlabs.com). Samples were viewed at
3600 with a Nikon TE300 inverted microscope.
Supporting Information
Figure S1. IFN-b Induction in Peritoneal Macrophages and Intra-
cellular Growth Curve of LLO- Minus Mutant in MyD88-Deﬁcient
Macrophages
(A) Real-time PCR analysis of IFN-b induction by activated and non-
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NOD2 Senses Ligands Generated in the Phagosomeactivated resident peritoneal macrophages infected with w.t. L.
monocytogenes and LLO-minus mutant.
(B) Intracellular growth curve of LLO-minus mutant in MyD88-
deﬁcient BMD macrophages with and without IFN-c treatment.
Found at doi:10.1371/journal.ppat.0030051.sg001 (148 KB PDF).
Table S1. The Most Highly Induced Genes by BMD Activated
Macrophages Infected with the LLO-Minus Mutant
MEEBO array analysis of the complete transcription response of
activated and non-activated macrophages to infection with LLO-
minus mutant, at 5 h.p.i. Gene induction in activated macrophages
was normalized to non-activated macrophages, and the 20 most
highly induced genes in activated macrophages infected with LLO-
minus mutant are presented.
Found at doi:10.1371/journal.ppat.0030051.st001 (13 KB PDF).
Accession Numbers
MEEBO (http://meebo.ucsf.edu:8080/meebo/meeboQuery.html) gene
ID numbers for the genes and gene products discussed in this paper
are 59 nucleotidase (mMC016279); C-C receptor like 2 (mMC024156);
C-X-C ligand 1 (mMC023634); CXC ligand 11 (mMC011370); dual
speciﬁcity phosphatase 16 (mMA034830); IFN activated gene 205
(mMA032762); IFN-b (mMC16397); IL-1a (mMR001431); IL-1 recep-
tor agonist (mMC015067); IL-4 (mMC019427); IL-12 (mMC018187);
IL-15 (mMC009424); IL-15 receptor (mMA033400); Mda5 helicase
(mMC010553); myxovirus resistance gene (mMC023295); NF-jB light
polypeptide zeta (mMC002655); NOD2 receptor (mMR030202);
TNFa-induced protein 2 (mMC011682); and TNF receptor super-
family member 5 (mMR028074).
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